Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cencora Inc.

288.94
+0.53000.18%
Post-market: 288.940.00000.00%19:58 EDT
Volume:1.30M
Turnover:374.77M
Market Cap:56.00B
PE:33.65
High:289.75
Open:285.89
Low:285.24
Close:288.41
Loading ...

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks
·
02 Apr

GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm

Zacks
·
02 Apr

Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

Zacks
·
01 Apr

CVS Health and Deckers Are the S&P 500's Best and Worst for the Quarter. Here's Why. -- Barrons.com

Dow Jones
·
01 Apr

Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical

Zacks
·
28 Mar

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Zacks
·
28 Mar

Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Dow Jones
·
28 Mar

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

Zacks
·
27 Mar

Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?

Zacks
·
27 Mar

CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell?

Zacks
·
27 Mar

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

Zacks
·
27 Mar

Cencora Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
27 Mar

Deutsche Bank Adjusts Cencora Price Target to $285 From $24

MT Newswires Live
·
27 Mar

GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis

Zacks
·
24 Mar

GEHC Stock Gains Following Cardiology Solutions Portfolio Expansion

Zacks
·
21 Mar

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

Zacks
·
18 Mar

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Zacks
·
18 Mar

Cencora Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar

Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus

Zacks
·
17 Mar

Cencora, Inc. (COR): Among Top Insider Sales Last Month

Insider Monkey
·
17 Mar